India Pesticides Ltd
NSE: IPL BSE: 543311Chemicals
India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]
₹164
52W: ₹125 — ₹246
PE 16.7 · Book ₹83.6 · +96% vs bookMarket Cap₹1,889 Cr
Stock P/E16.7Price to Earnings
ROCE13%Return on Capital
ROE9.73%Return on Equity
Div. Yield0.45%Face Value ₹1
Strengths
- +Company is almost debt free.
- +Company is expected to give good quarter
Weaknesses
- −The company has delivered a poor sales growth of 11.6% over past five years.
- −Company has a low return on equity of 12.2% over last 3 years.
- −Dividend payout has been low at 10.1% of profits over last 3 years
- −Company has high debtors of 152 days.
- −Promoter holding has decreased over last 3 years: -3.55%
Shareholding Pattern
Promoters63.65%
FIIs1.87%
DIIs0.02%
Public34.46%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 63.61% | 63.61% | 63.61% | 63.62%▲0.0 | 63.62% | 63.65%▲0.0 | 63.65% | 63.65% |
| FIIs | 0.26% | 0.32%▲0.1 | 1.75%▲1.4 | 1.84%▲0.1 | 2.52%▲0.7 | 2.78%▲0.3 | 1.88%▼0.9 | 1.87%▼0.0 |
| DIIs | 0.04% | 0.05%▲0.0 | 0.06%▲0.0 | 0%▼0.1 | 0% | 0.02%▲0.0 | 0.03%▲0.0 | 0.02%▼0.0 |
| Public | 36.1% | 36.01%▼0.1 | 34.59%▼1.4 | 34.55%▼0.0 | 33.85%▼0.7 | 33.54%▼0.3 | 34.43%▲0.9 | 34.46%▲0.0 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 151 | 127 | 220 | 229 | 172 | 208 | 275 | 290 | 226 |
| Expenses | 175 | 118 | 123 | 192 | 195 | 145 | 176 | 230 | 241 | 188 |
| Operating Profit | 27 | 33 | 4 | 29 | 34 | 27 | 32 | 46 | 49 | 38 |
| OPM % | 13% | 22% | 3% | 13% | 15% | 16% | 15% | 17% | 17% | 17% |
| Net Profit | 20 | 24 | 1 | 20 | 26 | 17 | 22 | 35 | 32 | 23 |
| EPS ₹ | 1.72 | 2.12 | 0.09 | 1.74 | 2.3 | 1.51 | 1.94 | 3.07 | 2.78 | 2.01 |
AI Insights
Revenue Trend
TTM revenue at ₹999Cr, up 20.5% YoY. OPM at 17%.
Debt Position
Borrowings at ₹31Cr. Debt-to-equity ratio: 0.03x. Healthy balance sheet.
Capex Cycle
CWIP at ₹27Cr (8% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.02% (-1.79pp change). FIIs: 1.87% (+1.48pp change). Promoters hold 63.65%.
Margin & Efficiency
ROCE improving from 0% (Mar 2017) to 13% (Mar 2025). Working capital days: 179.
Valuation
PE 16.7x with 13% ROCE. Price is 96% above book value of ₹83.6. Dividend yield: 0.45%.
Recent Announcements
- Board Meeting Intimation for Board Meeting 5 May - Board meeting on 23 May 2026 to approve FY26 results and consider final dividend.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Submitted Regulation 74(5) certificate for quarter and year ended 31 March 2026.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 30 Mar
- Closure of Trading Window 26 Mar
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 25 Mar
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse